Rockwell Medical (RMTI) Payables (2010 - 2026)
Rockwell Medical (RMTI) posted Payables of $3.5 million for Q1 2026, up 55.19% on a QoQ basis from $2.3 million in Q4 2025, and up 76.31% year-over-year from $2.0 million in Q1 2025.
Rockwell Medical (RMTI) Payables (2010 - 2026) Analysis & Trends
Rockwell Medical's Payables history runs 17 years deep, the most recent figure standing at $3.5 million for Q1 2026.
- Quarterly Payables rose 76.31% year-over-year to $3.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.5 million (up 76.31% YoY) and the FY2025 annual result came in at $2.3 million, down 27.86% from the prior year.
- Payables was $3.5 million for Q1 2026 at Rockwell Medical, up from $2.3 million in the prior quarter.
- Across five years, Payables topped out at $5.9 million in Q2 2023 and bottomed at $2.0 million in Q3 2025.
- A 5-year average of $3.6 million and a median of $3.5 million in 2026 frame the typical range for Payables.
- Annual changes were most pronounced in 2023 — Payables jumped 101.46% — and 2025, when it slumped 59.5%.
- Rockwell Medical's Payables stood at $4.1 million in 2022, then advanced by 17.44% to $4.8 million in 2023, then slumped by 34.1% to $3.1 million in 2024, then fell by 27.86% to $2.3 million in 2025, then soared by 55.19% to $3.5 million in 2026.
- Business Quant data shows RMTI's Payables at $3.5 million in Q1 2026, $2.3 million in Q4 2025, and $2.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 4.96 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 2.60 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 731.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 3.13 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 498.30 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 8.82 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.75 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 773.00 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 372.00 Mn |
| 10 | Rockwell Medical | 25.77 Mn | 1.88 Mn | 2.90 Mn | 3.51 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.51 Mn |
| Dec 31, 2025 | 2.26 Mn |
| Sep 30, 2025 | 1.99 Mn |
| Jun 30, 2025 | 2.16 Mn |
| Mar 31, 2025 | 1.99 Mn |
| Dec 31, 2024 | 3.14 Mn |
| Sep 30, 2024 | 3.08 Mn |
| Jun 30, 2024 | 4.02 Mn |
| Mar 31, 2024 | 4.92 Mn |
| Dec 31, 2023 | 4.76 Mn |
| Sep 30, 2023 | 3.93 Mn |
| Jun 30, 2023 | 5.93 Mn |
| Mar 31, 2023 | 5.20 Mn |
| Dec 31, 2022 | 4.05 Mn |
| Sep 30, 2022 | 3.05 Mn |
| Jun 30, 2022 | 2.94 Mn |
| Mar 31, 2022 | 4.22 Mn |
| Dec 31, 2021 | 3.74 Mn |
| Sep 30, 2021 | 4.83 Mn |
| Jun 30, 2021 | 4.93 Mn |